Review
Copyright ©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 527-541
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.527
Table 1 Sources of exosomes and their roles in ulcerative colitis
Exosomes source
Pivotal molecules
Role of the exosomes
Conclusion
Ref. 
Stem cellmiR-378a-5pInhibiting pyroptosis through NLRP3/caspase-1 signalingBeneficial[71]
Stem cellmiR-539-5pInhibiting pyroptosis through NLRP3/caspase-1 signalingBeneficial[72]
Stem cellmiRNASuppressing pyroptosisBeneficial[73]
Stem cellmiR-203a-3p.2Suppressing macrophage pyroptosis induced by caspase11/4Beneficial[74]
Stem cellNARegulating the Treg populationBeneficial[75]
Stem cellNAModulating the gut metagenomics-metabolomics-farnesoid X receptor axisBeneficial[76]
Stem cellNAPolarizing M2b macrophagesBeneficial[77]
Stem cellmiR-146aInhibiting SUMO1 expression and its binding to β-cateninBeneficial[78]
Stem cellmiR-216a-5pInducing macrophage M2 polarization by regulating the HMGB1/TLR4/NF-κB signaling pathwayBeneficial[79]
Stem cellNARegulating the Th17/Treg balanceBeneficial[80]
Stem cellNARepairing intestinal barrier via TSG-6Beneficial[81]
Stem cellmiR-125a, miR-125bRepressing Th17 cell differentiationBeneficial[82]
Stem cellNALimiting intestinal epithelial cells reactive oxygen species accumulation and DNA damage through HIF-1αBeneficial[83]
Stem cellmiR-181aImproving gut microbiota composition, barrier function, and inflammatory statusBeneficial[84]
Stem cellNASuppressing inflammationBeneficial[85]
Stem cellNAModulating Th1/Th17 and Treg cell responsesBeneficial[86]
Stem cellNAAttenuating inflammation, oxidative stress and apoptosisBeneficial[87]
Stem cellNAStimulating epithelial repair and decreasing epithelial apoptosisBeneficial[88]
Stem cellNAModulating the expression of IL-7 in macrophagesBeneficial[89]
Stem cellNADownregulating intestine ferroptosisBeneficial[90]
Melatonin and stem cellNASuppressing inflammation, oxidative stress, apoptosis, and fibrosisBeneficial[91]
Dendritic CellmiR-146aTargeting Traf6, IRAK-1, and NLRP3 in macrophagesBeneficial[92]
Dendritic cellNAPreventing colon damageBeneficial[93]
Dendritic cellNADownregulating the expression of IL-2, IFN-γ and TNF-αBeneficial[94]
Dendritic cellNACarrying drug to dendritic cellBeneficial[95]
M2 macrophagemiR-590-3pSuppressing LATS1 and activating the YAP/β-catenin signalingBeneficial[96]
M1 macrophageMiR-21a-5pDecreasing E-cadherin and subsequent ILC2 activationUnfavorable[97]
IntestinalNAPromoting wound healingBeneficial[98]
Visceral adipose tissuemiR-155Promoting macrophage M1 polarizationUnfavorable[99]
SerumNAInhibiting MCP-1 and MIP-1α expression via NLRP12-Notch signaling pathwayBeneficial[100]
SerumProteinsImplicating macrophage activationNA[101]
Helicobacter pyloriNAAggravating intestinal epithelium barrier dysfunction by facilitating Claudin-2 expressionUnfavorable[102]
MilkNASuppressing inflammationBeneficial[103]
Cow and human milkmiRNA-320, 375, and Let-7Downregulating DNA methyltransferase 1 (DNMT1) and DNMT3Beneficial[104]
Bovine colostrumNASuppressing inflammation and oxidative stressBeneficial[105]
Table 2 Sources of exosomes and their roles in NOD-like receptor family pyrin domain containing 3 inflammasome regulation
Exosomes source
Pivotal molecules
Role of the exosomes
Ref.
Stem cellmiR-378a-5pInhibiting NLRP3 inflammasome activation[71]
Stem cellmiR-539-5pInhibiting NLRP3 inflammasome activation[72]
Stem cellNAInhibiting NLRP3 inflammasome activation[73]
Stem cellmiR-17Inhibiting NLRP3 inflammasome activation by targeting TXNIP[106]
Stem cellNAInhibiting NLRP3 inflammasome activation by down-regulating ROS levels[107]
Stem cellNAInhibiting TLR4-NLRP3-mediated pyroptosis[108]
PlasmaNAInhibiting pyroptosis through the TLR4/NF-κB pathway[109]
Stem cellNAInhibiting NLRP3 inflammasome-mediated pyroptosis by promoting AMPK-dependent autophagic flux[110]
Stem cellcircHIPK3Inhibiting pyroptosis by down-regulating miR-421 to increase FOXO3A expression[111]
Stem cellmiRNA Let-7Inhibiting NLRP3 inflammasome activation by down-regulating ROS levels[112]
Stem cellmiR-188-3pTargeting NLRP3[113]
Stem cellNAInhibiting the tumor suppressor Rb1-mediated NLRP3 inflammasome[114]
Stem cellNAInhibiting pyroptosis through the TLR4 pathway[115]
Cancer cellsmiR-21Repressing PTEN and BRCC3 to facilitate NLRP3 phosphorylation[116]
Stem cellcirc_003564Attenuating inflammasome-related pyroptosis[117]
Stem cellmiR-100-5pInhibiting the FOXO3A/NLRP3 pathway[118]
Stem cellmiR-17-5pSuppressing TXNIP-NLRP3 inflammasome[119]
PericytecircEhmt1Upregulating NFIA levels to suppress NLRP3-mediated inflammasome formation[120]
B cellsmiR-BART15Targeting the miR-223 binding site in the NLRP3 3′-untranslated region[121]
Stem cellNASuppressing NLRP3 inflammasome activation[122]
Stem cellNASuppressing NLRP3 inflammasome activation[123]
Stem cellNASuppressing NLRP3 inflammasome activation[124]
Stem cellNARegulating pyroptosis via the miR-146a-5p-TRAF6 axis[125]
M2 macrophageNASuppressing the ROS/NLRP3 pathway[126]
Stem cellNAAttenuating inflammasome-related pyroptosis[127]
Cancer cellsNASuppressing NLRP3 inflammasome activation[128]
Stem cellmiR-23bAttenuating inflammasome-related pyroptosis[129]
Stem cellmiR-223-3pTargeting NLRP3[130]
Stem cellNASuppressing NLRP3 inflammasome activation[131]
Stem cellNAModulating miR-126 via targeting HMGB1[132]
PlasmaNAPromoting the autophagic degradation of NLRP3[133]
Stem cellmiR-223Downregulating NLRP3 expression[134]
Dendritic cellNADownregulating NLRP3 expression[135]
M2 macrophagemicroRNA-148aInhibiting the TLR4/NF-κB/NLRP3 pathway[136]
SalivarymiR-223-3pAttenuating inflammasome-related pyroptosis[137]
NeutrophilsmiR-30d-5pUpregulating NLRP3 expression through the NF-κB pathway[138]
Cancer cellsTRIM59Inducing the ubiquitination of ABHD5 to activate the NLRP3 inflammasome activation[139]
Epithelium cellsNAUpregulating the NLRP3 inflammasome[140]
SerumNAActivating the NLRP3 inflammasome[141]
PlasmaNATriggering NLRP3-dependent pyroptosis[142]
PlasmaNATriggering NLRP3 inflammasome[143]
PlasmaNAActivating the NLRP3 inflammasome[144]
SerumNAInhibiting the NF-κB/NLRP3 pathway[145]
PlasmamiRNA-223Inhibiting NLRP3[146]
Renal tissuesNASuppressing NLRP3 activation[147]